161 related articles for article (PubMed ID: 21122318)
1. [Study of the platelet GP specific antibodies and HLA antibodies expression in platelet transfusion refractoriness patients].
Xia WJ; Ye X; Deng J; Chen YK; Xu XZ; Ding HQ; Luo GP; Fu YS
Zhonghua Xue Ye Xue Za Zhi; 2010 Sep; 31(9):594-8. PubMed ID: 21122318
[TBL] [Abstract][Full Text] [Related]
2. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
[TBL] [Abstract][Full Text] [Related]
3. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H
Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
[TBL] [Abstract][Full Text] [Related]
4. Establishment of platelet donor registry improves the treatment of platelet transfusion refractoriness in Guangzhou region of China.
Xia WJ; Ye X; Tian LW; Xu XZ; Chen YK; Luo GP; Bei CH; Deng J; Santoso S; Fu YS
Transfus Med; 2010 Aug; 20(4):269-74. PubMed ID: 20136782
[TBL] [Abstract][Full Text] [Related]
5. Alloantibodies to human platelet glycoprotein antigens (HPA) and HLA class 1 in a cross section of Nigerian antenatal women.
Jeremiah ZA; Atiegoba AI; Mgbere O
Hum Antibodies; 2011; 20(3-4):71-5. PubMed ID: 22129676
[TBL] [Abstract][Full Text] [Related]
6. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
[TBL] [Abstract][Full Text] [Related]
7. Platelet alloantibodies in transfused patients.
Kiefel V; König C; Kroll H; Santoso S
Transfusion; 2001 Jun; 41(6):766-70. PubMed ID: 11399817
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of transfusion effect of different platelet matching schemes in patients with platelet transfusion refractoriness].
Liang YJ; Wang H; Zhao PZ; Wang F; Li Q; Xu Y; Wu YX; Zhang DM; He XH
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(11):865-869. PubMed ID: 38462363
[No Abstract] [Full Text] [Related]
9. Platelet-specific antibodies in HLA-immunized patients receiving chronic platelet support.
Sanz C; Freire C; Alcorta I; Ordinas A; Pereira A
Transfusion; 2001 Jun; 41(6):762-5. PubMed ID: 11399816
[TBL] [Abstract][Full Text] [Related]
10. The role of alloantibodies against human platelet antigen-15 in multiply platelet transfused patients.
Matsuhashi M; Tsuno NH; Sone S; Mishima Y; Nagura Y; Watanabe-Okochi N; Ikeda T; Kashiwase K; Fukuda S; Iriyama T; Hyodo H; Yamashita T; Kamei Y; Arai S; Minami M; Fujii T; Kurokawa M; Tozuka M; Takahashi K; Santoso S
Transfusion; 2014 Apr; 54(4):1093-9. PubMed ID: 24147542
[TBL] [Abstract][Full Text] [Related]
11. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
Amemiya Y
Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients.
Jia Y; Li W; Liu N; Zhang K; Gong Z; Li D; Wang L; Wang D; Jing Y; Wang J; Shan X
Transfus Med; 2014 Dec; 24(6):406-10. PubMed ID: 25327352
[TBL] [Abstract][Full Text] [Related]
13. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
Basire A; Picard C
Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
[TBL] [Abstract][Full Text] [Related]
14. Post-transfusion purpura (PTP) associated with anti-HPA-1a, anti-HPA-2b and anti-HPA-3a antibodies.
Lucas GF; Pittman SJ; Davies S; Solanki T; Brüggemann K
Transfus Med; 1997 Dec; 7(4):295-9. PubMed ID: 9510928
[TBL] [Abstract][Full Text] [Related]
15. Primary refractoriness to platelet transfusion caused by Nak(a) antibody alone.
Fujino H; Ohta K; Taniue J; Nagao N; Hino M; Yamane T; Koh KR; Takeoka Y; Hirose A; Aoyama Y; Nakamae H; Terada Y; Takubo T; Tatsumi N
Vox Sang; 2001 Jul; 81(1):42-4. PubMed ID: 11520415
[TBL] [Abstract][Full Text] [Related]
16. [3 polymorphisms of gene GP IIb and the function of GP IIb T13959 G in the platelet transfusion refractoriness].
Liu J; Chen FP; Ma JQ; Jian ZF; Xing XW; Li X; Jiang TB; Zhou Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):584-9. PubMed ID: 17767046
[TBL] [Abstract][Full Text] [Related]
17. Detection and identification of platelet antibodies using a sensitive multiplex assay system-platelet antibody bead array.
Metzner K; Bauer J; Ponzi H; Ujcich A; Curtis BR
Transfusion; 2017 Jul; 57(7):1724-1733. PubMed ID: 28439930
[TBL] [Abstract][Full Text] [Related]
18. Minor impact of patient alloantibodies against human platelet antigen (HPA)-15 in the effectiveness of platelet transfusion: A pilot study.
Inoue H; Sakamoto R; Nishimiya H; Sakamoto H; Terasu S; Aminaka R; Koh Y; Takihara Y; Hirayama F; Kuroishi A
Transfusion; 2021 Mar; 61(3):738-743. PubMed ID: 33166416
[TBL] [Abstract][Full Text] [Related]
19. Severe neonatal alloimmune thrombocytopenia due to anti-HPA-3a.
Boehlen F; Kaplan C; de Moerloose P
Vox Sang; 1998; 74(3):201-4. PubMed ID: 9595650
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of immunological platelet refractoriness by histocompatibility.
Fagundes IS; Franz JM; Jobim MS; Arend A; Merzoni J; Cardone JM; Gil B; Sekine L; Jobim LF
Hum Immunol; 2020 May; 81(5):197-201. PubMed ID: 32067841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
